vs

Side-by-side financial comparison of GREENPOWER MOTOR Co INC. (GP) and MediWound Ltd. (MDWD). Click either name above to swap in a different company.

GREENPOWER MOTOR Co INC. is the larger business by last-quarter revenue ($7.2M vs $5.7M, roughly 1.3× MediWound Ltd.). GREENPOWER MOTOR Co INC. runs the higher net margin — -65.6% vs -233.3%, a 167.7% gap on every dollar of revenue. On growth, MediWound Ltd. posted the faster year-over-year revenue change (12.7% vs -11.5%).

GreenPower Motor Company Inc. is a Canadian electric bus manufacturer and distributor in North America. The company fabricates multiple zero-emission models, including transit buses, school buses, and double decker buses. GreenPower headquarters are in Vancouver, British Columbia, with a sales office in Rancho Cucamonga, California; an assembly facility in Porterville, California; and a production facility in South Charleston, West Virginia. Its stock is traded on Nasdaq the United States.

MediWound Ltd. is a biopharmaceutical company specializing in the research, development, production and commercialization of innovative products for burn care, chronic wound treatment and soft tissue repair. It operates mainly across North America, Europe and Asia, serving hospitals, healthcare providers and patients in the wound care segment.

GP vs MDWD — Head-to-Head

Bigger by revenue
GP
GP
1.3× larger
GP
$7.2M
$5.7M
MDWD
Growing faster (revenue YoY)
MDWD
MDWD
+24.3% gap
MDWD
12.7%
-11.5%
GP
Higher net margin
GP
GP
167.7% more per $
GP
-65.6%
-233.3%
MDWD

Income Statement — Q3 FY2025 vs Q2 FY2025

Metric
GP
GP
MDWD
MDWD
Revenue
$7.2M
$5.7M
Net Profit
$-4.7M
$-13.3M
Gross Margin
14.6%
23.5%
Operating Margin
-100.1%
Net Margin
-65.6%
-233.3%
Revenue YoY
-11.5%
12.7%
Net Profit YoY
-2.1%
-111.2%
EPS (diluted)
$-0.17
$-1.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GP
GP
MDWD
MDWD
Q2 25
$5.7M
Q4 24
$7.2M
Q3 24
$5.3M
Q2 24
$3.0M
$5.1M
Q4 23
$8.2M
Q3 23
$8.4M
Q2 23
$17.6M
$4.8M
Q4 22
$12.8M
Net Profit
GP
GP
MDWD
MDWD
Q2 25
$-13.3M
Q4 24
$-4.7M
Q3 24
$-4.7M
Q2 24
$-5.4M
$-6.3M
Q4 23
$-4.6M
Q3 23
$-4.3M
Q2 23
$-2.8M
$916.0K
Q4 22
$-3.4M
Gross Margin
GP
GP
MDWD
MDWD
Q2 25
23.5%
Q4 24
14.6%
Q3 24
8.6%
Q2 24
7.4%
8.8%
Q4 23
16.6%
Q3 23
14.6%
Q2 23
15.9%
23.8%
Q4 22
17.4%
Operating Margin
GP
GP
MDWD
MDWD
Q2 25
-100.1%
Q4 24
Q3 24
Q2 24
-88.6%
Q4 23
Q3 23
Q2 23
-84.0%
Q4 22
Net Margin
GP
GP
MDWD
MDWD
Q2 25
-233.3%
Q4 24
-65.6%
Q3 24
-87.9%
Q2 24
-179.8%
-124.5%
Q4 23
-56.9%
Q3 23
-50.4%
Q2 23
-16.0%
19.2%
Q4 22
-26.4%
EPS (diluted)
GP
GP
MDWD
MDWD
Q2 25
$-1.23
Q4 24
$-0.17
Q3 24
$-0.18
Q2 24
$-0.21
$-0.68
Q4 23
$-0.19
Q3 23
$-0.17
Q2 23
$-0.11
$0.10
Q4 22
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GP
GP
MDWD
MDWD
Cash + ST InvestmentsLiquidity on hand
$621.1K
$1.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.1M
$20.1M
Total Assets
$37.4M
$67.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GP
GP
MDWD
MDWD
Q2 25
$1.1M
Q4 24
$621.1K
Q3 24
$116.9K
Q2 24
$528.3K
$3.8M
Q4 23
$4.0M
Q3 23
$2.0M
Q2 23
$1.5M
$19.2M
Q4 22
$609.6K
Stockholders' Equity
GP
GP
MDWD
MDWD
Q2 25
$20.1M
Q4 24
$2.1M
Q3 24
$4.2M
Q2 24
$8.6M
$17.9M
Q4 23
$18.1M
Q3 23
$22.3M
Q2 23
$26.2M
$34.9M
Q4 22
$27.3M
Total Assets
GP
GP
MDWD
MDWD
Q2 25
$67.0M
Q4 24
$37.4M
Q3 24
$39.4M
Q2 24
$43.5M
$57.3M
Q4 23
$50.2M
Q3 23
Q2 23
$64.4M
Q4 22

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GP
GP
MDWD
MDWD
Operating Cash FlowLast quarter
$-1.1M
$-5.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GP
GP
MDWD
MDWD
Q2 25
$-5.8M
Q4 24
$-1.1M
Q3 24
$-1.3M
Q2 24
$-3.2M
$-3.6M
Q4 23
$1.4M
Q3 23
$-5.4M
Q2 23
$7.8M
$-5.3M
Q4 22
Cash Conversion
GP
GP
MDWD
MDWD
Q2 25
Q4 24
Q3 24
Q2 24
Q4 23
Q3 23
Q2 23
-5.73×
Q4 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons